briakinumab

Ligand id: 9213

Name: briakinumab

IUPHAR Pharmacology Education Project (PEP) logo

View more information in the IUPHAR Pharmacology Education Project: pericyazine

Classification
Compound class Antibody
International Nonproprietary Names
INN number INN
9153 briakinumab
Synonyms
ABT-874 | J-695 | J695 | Ozespa
Database Links
Specialist databases
IMGT/mAb-DB 162
Other databases
GtoPdb PubChem SID 315661289
Search PubMed clinical trials briakinumab
Search PubMed titles briakinumab
Search PubMed titles/abstracts briakinumab
Comments
Briakinumab is a recombinant, fully human, IgG1 investigational monoclonal antibody targeting the shared p40 subunit of IL-12 and IL-23. Peptide sequences matching those of briakinumab are claimed in patent US6914128 'Human antibodies that bind human IL-12 and methods for producing' [2].